Carna Biosciences, Inc. (TYO:4572)

Carna Biosciences Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 11, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	8,058	6,814	5,729	8,950	7,390	14,666
Market Cap Growth	66.78%	18.93%	-35.99%	21.11%	-49.61%	-2.43%
Enterprise Value	8,773	6,354	3,506	5,737	3,994	11,150
Last Close Price	420.00	356.00	300.00	522.00	520.00	1102.00
PS Ratio	13.02	11.77	9.01	5.51	5.33	7.27
PB Ratio	-49.44	22.12	2.32	2.31	2.03	3.40
P/TBV Ratio	-	22.12	2.32	2.31	2.03	3.40
EV/Sales Ratio	14.18	10.97	5.51	3.53	2.88	5.53
Debt / Equity Ratio	-13.48	2.32	0.02	0.05	0.08	0.13
Net Debt / Equity Ratio	-4.39	0.64	-0.83	-0.70	-0.85	-0.76
Net Debt / EBITDA Ratio	-	-0.10	1.00	2.50	2.49	6.40
Net Debt / FCF Ratio	-	-0.09	1.48	1.60	3.69	2.08
Asset Turnover	0.28	0.29	0.18	0.38	0.29	0.39
Inventory Turnover	1.27	1.24	1.16	1.36	1.50	1.26
Quick Ratio	11.94	3.67	9.89	9.81	8.17	6.54
Current Ratio	16.12	6.99	12.33	11.18	9.41	6.87
Return on Equity (ROE)	-243.72%	-156.08%	-68.60%	-30.65%	-33.92%	-13.13%
Return on Assets (ROA)	-58.03%	-64.83%	-36.44%	-16.21%	-16.37%	-6.46%
Return on Invested Capital (ROIC)	-385.19%	-446.24%	-260.48%	-129.21%	-159.25%	-107.49%
Return on Capital Employed (ROCE)	-97.90%	-195.60%	-81.40%	-28.10%	-33.20%	-11.40%
Earnings Yield	-27.12%	-31.86%	-38.02%	-12.87%	-18.25%	-3.64%
FCF Yield	-	-31.82%	-24.21%	-18.86%	-11.29%	-10.75%
Buyback Yield / Dilution	-3.97%	-6.71%	-6.61%	-23.37%	-7.26%	-3.22%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.